Association between bone mineral density and cognitive decline in older women

Journal of the American Geriatrics Society

Volumn 47, Issue 10, 1999, Pages 1176-1182

  Yaffe, Kristine ^a,b,c,f   Browner, Warren ^b,c   Cauley, Jane ^d   Launer, Lenore ^e   Harris, Tamara ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bone mineral density; Cognition; Dementia; Estrogen; Older women

Indexed keywords

ESTROGEN;

AGED; ARTICLE; BONE; BONE DENSITY; BONE MINERAL; BONE RADIOGRAPHY; COGNITIVE DEFECT; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; TASK PERFORMANCE;

EID: 0032863152     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb05196.x     Document Type: Article

References (56)

1. Kokmen E, Beard CM, O'Brien PC, Kurland LT. Epidemiology of dementia in Rochester, Minnesota. Mayo Clin Proc 1996;71:275-282.
2. Ganguli M, Seaberg E, Belle S et al. Cognitive impairment and the use of health services in an elderly rural population: The MoVIES project. Monongahela Valley Independent Elders Survey. J Am Geriatr Soc 1993;41:1065-1070.
3. Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ 1996;312:608-611.
4. Kimura D. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav 1995;29:312-321.
5. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-357.
6. Henderson VW, Paganini HA, Emanuel CK et al. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 1994;51:896-900.
7. Kawas C, Resnick S, Morrison A et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-1521.
8. Tang MX, Jacobs D, Stern Y et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
9. Ohkura T, Isse K, Akazawa K et al. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 1994;41:361-371.
10. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA 1998;279: 688-695.
11. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993;269:2637-2641.
12. Brenner DE, Kukull WA, Stergachis A et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study. Am J Epidemiol 1994;140:262-267.
13. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-995.
14. Yaffe K, Grady D, Pressman A, Cummings S. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc 1998;46:816-821.
15. Fox KM, Magaziner J, Sherwin R et al. Reproductive correlates of bone mass in elderly women. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1993;8:901-908.
16. Heiss CJ, Sanborn CF, Nichols DL et al. Associations of body fat distribution, circulating sex hormones, and bone density in postrnenopausal women. J Clin Endocrinol Metab 1995;80:1591-1596.
17. Nguyen TV, Jones G, Sambrook PN et al. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab 1995;80:2709-2714.
18. Eiken P, Nielsen SP, Kolthoff N. Effects on bone mass after eight years of hormonal replacement therapy. Br J Obstet Gynaecol 1997;104:702-707.
19. Bauer DC, Browner WS, Cauley JA et al. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 1993;118:657-665.
20. Cauley JA, Lucas FL, Kuller LH et al. Bone mineral density and risk of breast cancer in older women: The study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 1996;276:1404-1408.
21. Zhang Y, Kiel DP, Kreger BE et al. Bone mass and the risk of breast cancer among postrnenopausal women. N Engl J Med 1997;336:611-617.
22. Cummings SR, Nevitt MC, Browner WS et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767-773.
23. Steiger P, Cummings SR, Black DM et al. Age-related decrements in bone mineral density in women over 65. J Bone Miner Res 1992;7:625-632.
24. Black DM, Palermo L, Nevitt MC et al. Comparison of methods for defining prevalent vertebral deformities: The Study of Osteoporotic Fractures. J Bone Miner Res 1995;10:890-902.
25. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
26. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation, 1988.
27. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
28. Ganguli M, Belle S, Ratcliff G et al. Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: The MoVIES project. J Gerontol 1993;48:M152-161.
29. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull 1988;24: 709-711.
30. Melton LJ III, Beard CM, Kokmen E et al. Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc 1994;42:614-619.
31. Johansson C, Skoog I. A population-based study on the association between dementia and hip fracture. Aging (Milano) 1996;8:189-196.
32. Pocock N, Eisman J, Gwinn T et al. Muscle strength, physical fitness, and weight but not age predict femoral neck bone mass. J Bone Miner Res 1989; 4:441-448.
33. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 1996;44:1147-1152.
34. Langlois JA, Harris T, Looker AC, Madans J. Weight change between age 50 years and old age is associated with risk of hip fracture in white women aged 67 years and older. Arch Intern Med 1996;156:989-994.
35. Eriksen EF, Colvard DS, Berg NJ et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988;241:84-86.
36. McEwen BS. How do sex and stress hormones affect nerve cells? Ann N Y Acad Sci 1994;743:1-16, 17-18.
37. Egeland GM, Kuller LH, Matthews KA et al. Premenopausal determinants of menopausal estrogen use. Prev Med 1991;20:343-349.
38. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;115:455-456.
39. Petitti DB. Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies? Ann Epidemiol 1994;4:115-118.
40. Mortimer JA, Graves AB. Education and other socioeconomic determinants of dementia and Alzheimer's disease. Neurology 1993;43(suppl 4):S39-44.
41. Michelson D, Stratakis C, Hill L et al. Bone mineral density in women with depression. N Engl J Med 1996;335:1176-1181.
42. Schweiger U, Deuschle M, Korner A et al. Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 1994;151:1691-1693.
43. Devanand DP, Sano M, Tang MX et al. Depressed mood and the incidence of Alzheimer's disease in the elderly. Arch Gen Psychiatry 1996;53:175-182.
44. Browner WS, Pressman AR, Nevitt MC et al. Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke 1993;24:940-946.
45. Pasquier F, Leys D. Why are stroke patients prone to develop dementia? J Neurol 1997;244:135-142.
46. Sapolsky RM. Why stress is bad for your brain. Science 1996;273:749-750.
47. Lupien S, Lecours AR, Lussier I et al. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 1994;14:2893-2903.
48. Zelissen PM, Croughs RJ, van Rijk PP, Raymakers JA. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann Intern Med 1994;120:207-210.
49. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 1996;47:387-400.
50. Yaffe K, Cauley J, Sands L, Browner W. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Archive Neurol 1997;54:1110-1114.
51. Cauley J, Zmuda J, Yaffe K et al. Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk - The study of osteoporotic fractures. J Bone Miner Res 1999;14:1175-1181.
52. Albert SM, Gurland B, Maestre et al. APOE genotype influences functional status among elderly without dementia. Am J Med Genet 1995;60: 583-587.
53. Blacker D, Haines JL, Rodes L et al. ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics. Neurology 1997;48:139-147.
54. Aronson MK, Ooi WL, Morgenstern H et al. Women, myocardial infarction, and dementia in the very old. Neurology 1990;40:1102-1106.
55. Looker AC, Johnston CC Jr, Wahner HW et al. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res 1995;10:796-802.
56. Melton LJ, Lane AW, Cooper C et al. Prevalence and incidence of vertebral deformities. Osteoporos Int 1993;3:113-119.